La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Cognex a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Cognex..

Cognex (NASDAQ:CGNX) Azioni, Catena delle Opzioni

Cognex

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's own cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

Cognex Corp

COGNEX ORD

Needham analyst James Ricchiuti maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and lowers the price target from $50 to $47.

News

Price Target

Analyst Ratings

CGNX

Needham Maintains Buy on Cognex, Lowers Price Target to $47

Guidance

Cognex Sees Q4 2024 Revenue $210M-$230M

Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.19 by 5.26 percent. The company reported quarterly sales of $234.74 million which beat the analyst consensus estimate of $233.03 million by 0.74 percent. This is a 19.01 percent increase over sales of $197.24 million the same period last year.

Earnings

Earnings Beats

Cognex Q3 2024 Adj EPS $0.20 Beats $0.19 Estimate, Sales $234.74M Beat $233.03M Estimate

Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">PBF Energy</h3>
<ul>
<li>The Trade: PBF Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>) 10% owner Control Empresarial de Capitales S.A. de C.V.<a href="https://www.benzinga.com/quote/PBF/analyst-ratings"> acquired a total of 1,210,000 shares at</a> an average price of $33.25. To acquire these shares, it cost around $40.2 million.</li>
<li>What's Happening: PBF Energy will release its earnings results for the third quarter 2024 on Thursday, Oct. 31.</li>
<li>What PBF Energy Does: PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States.</li>
</ul>
<h3 class="wp-block-heading">Talos Energy</h3>
<ul>
<li>The Trade: Talos Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TALO#NYSE">TALO</a>) 10% owner Control Empresarial de Capitales S.A. de C.V. acquired a total of 2,397,000 shares at an average price of $11.08. To acquire these shares, it cost around $26.5 million.</li>
<li>What's Happening: The company disclosed that its Ewing Bank 953 well has successfully discovered commercial quantities of oil and natural gas.</li>
<li>What Talos Energy Does: Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production.</li>
</ul>
<h3 class="wp-block-heading">Cognex</h3>
<ul>
<li>The Trade: Cognex Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) SVP, Chief Financial Officer Dennis Fehr <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 6,570 shares</a> at an average price of $38.04. To acquire these shares, it cost around $249,920.</li>
<li>What's Happening: On July 31, Cognex reported mixed second-quarter financial results.</li>
<li>What Cognex Does: Cognex Corp provides machine vision products that help automate manufacturing processes.</li>
</ul>
<h3 class="wp-block-heading">Lululemon Athletica</h3>
<ul>
<li>The Trade: Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) CEO Calvin McDonald <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 4,000 shares</a> at an average price of $260.00. The insider spent around $1.04 million to buy those shares.</li>
<li>What's Happening: On Aug. 29, Lululemon Athletica reported better-than-expected second-quarter EPS results.</li>
<li>What Lululemon Athletica Does: Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls.</li>
</ul>
Check This Out:<a href="https://www.benzinga.com/top-stories/24/09/40730015/jim-cramer-oklo-is-losing-money-hand-over-fist-but-this-private-equity-stock-is-a-buy"> </a>
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/09/40730015/jim-cramer-oklo-is-losing-money-hand-over-fist-but-this-private-equity-stock-is-a-buy">Jim Cramer: Oklo Is Losing Money &#8216;Hand-Over-Fist,&#8217; But This Private Equity Stock Is A Buy</a></li>
</ul>

Long Ideas

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

LULU

TALO

Over $40M Bet On PBF Energy? Check Out These 4 Stocks Executives Are Buying

WIIM

AAPL

AEIS

AEVA

ANET

ASNS

BBAI

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CRSR

DAKT

DELL

DOCN

DTST

EGIO

EVLV

FIVN

FLEX

GDDY

GTLB

KEYS

KOPN

LITE

LWLG

NSIT

PLUS

PSTG

SHOP

SNOW

VECO

ZBRA

Shares of companies within the broader tech sector are trading lower amid overall market weakness. Weakness may be due to August's ISM Manufacturing PMI data indicating an economic contraction.

DA Davidson analyst Matthew Summerville maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Neutral and lowers the price target from $41 to $39.

DA Davidson Maintains Neutral on Cognex, Lowers Price Target to $39

Stephens &amp; Co. analyst Tommy Moll reiterates Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Equal-Weight and maintains $45 price target.

Reiteration

Stephens & Co. Reiterates Equal-Weight on Cognex, Maintains $45 Price Target

ADBE

ALGM

APLD

AVGO

BILL

BRZE

CDNS

COMM

CSCO

DDOG

DOCU

ERIC

ESTC

FSLR

GOOG

GOOGL

INFY

INTC

INTU

IREN

MRVL

MSFT

NTAP

NTNX

NVDA

OKTA

ORCL

OUST

PANW

PCOR

PLTR

QRVO

SMCI

SMTC

SWKS

TOYO

TRMB

TWLO

VSAT

WDAY

ZETA

Shares of stocks in the broader tech sector are trading lower as stocks sell off amid concerns over the US economy.

Baird analyst Richard Eastman maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Neutral and lowers the price target from $46 to $42.

Baird Maintains Neutral on Cognex, Lowers Price Target to $42

Goldman Sachs analyst Joe Ritchie maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Sell and lowers the price target from $45 to $39.

Goldman Sachs Maintains Sell on Cognex, Lowers Price Target to $39

Cognex Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) reported mixed second-quarter financial results, after the<a href="https://www.benzinga.com/quote/CGNX"> closing bell on Wednesday</a>.
Cognex reported quarterly earnings of 23 cents per share which beat the analyst consensus estimate of 21 cents per share. The company reported quarterly sales of $239.00 million which missed the analyst consensus estimate of $240.39 million.
&#8220;Cognex delivered second quarter revenue and gross margin in line with expectations and operating expenses favorable to our guidance,&#8221; said Robert J. Willett, CEO. &#8220;Year-on-year revenue growth in the quarter was strong in our Logistics and Semiconductor end markets, however revenue across the rest of our factory automation business continues to be soft.&#8221;
Cognex shares fell 21.2% to close at $39.08 on Thursday.
These analysts made changes to their price targets on Cognex following earnings announcement.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/591b27b4290fa70001b1563e/james-ricchiuti">Needham analyst James Ricchiuti </a>maintained Cognex with a Buy and lowered the price target from $57 to $50.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58ac4af1b85e930001e6383a/jamie-cook">Truist Securities analyst Jamie Cook </a>maintained Cognex with a Buy and lowered the price target from $55 to $46.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40122820/amazon-apple-and-3-stocks-to-watch-heading-into-friday">Amazon, Apple And 3 Stocks To Watch Heading Into Friday</a></li>
</ul>

These Analysts Cut Their Forecasts On Cognex Following Q2 Results

Truist Securities analyst Jamie Cook maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and lowers the price target from $55 to $46.

Truist Securities Maintains Buy on Cognex, Lowers Price Target to $46

Needham analyst James Ricchiuti maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and lowers the price target from $57 to $50.

Needham Maintains Buy on Cognex, Lowers Price Target to $50

Cognex shares are trading lower after the company reported mixed Q2 financial results.

Cognex Expects Q3 Revenue of $225M-$240M, Slight Sequential Decrease From Q2 But Slight YoY Increase Excluding Moritex; Moritex To Contribute 10%-12% of Q3 Revenue; Adjusted Gross Margin Slightly Below 70%; Adjusted EBITDA Margin 16%-19%; Adjusted Effective Tax Rate 16%

Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.21 by 9.52 percent. The company reported quarterly sales of $239.00 million which missed the analyst consensus estimate of $240.39 million by 0.58 percent. This is a 1.45 percent decrease over sales of $242.51 million the same period last year.

Earnings Misses

Cognex Q2 2024 Adj EPS $0.23 Beats $0.21 Estimate, Sales $239.00M Miss $240.39M Estimate

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>Deutsche Bank increased Northrop Grumman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) price target from $474 to $575. Deutsche Bank analyst Scott Deuschle upgraded the stock from Hold to Buy. Northrop Grumman shares gained 2.1% to close at $480.30 on Friday. <a href="https://www.benzinga.com/quote/NOC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler cut the price target for The Charles Schwab Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) from $80 to $64. Piper Sandler analyst Patrick Moley downgraded the stock from Overweight to Neutral. Charles Schwab shares gained 0.5% to close at $66.60 on Friday. <a href="https://www.benzinga.com/quote/SCHW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Pivotal Research boosted the price target for Charter Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) from $400 to $435. Pivotal Research analyst Jeffrey Wlodarczak maintained a Buy rating. Charter Communications shares gained 16.6% to close at $367.62 on Friday. <a href="https://www.benzinga.com/quote/CHTR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stephens &amp; Co. boosted the price target for Texas Roadhouse, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) from $170 to $176. Stephens &amp; Co. analyst Jim Salera maintained an Equal-Weight rating. Texas Roadhouse shares rose 2% to close at $169.38 on Friday. <a href="https://www.benzinga.com/quote/TXRH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham boosted Cognex Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) price target from $48 to $57. Needham analyst James Ricchiuti maintained a Buy rating. Cognex shares rose 2% to close at $49.68 on Friday. <a href="https://www.benzinga.com/quote/CGNX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. cut the price target for Longeveron Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) from $12 to $10. HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintained a Buy rating. Longeveron shares rose 13.2% to close at $3.44 on Friday. <a href="https://www.benzinga.com/quote/LGVN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>WestPark Capital cut Data I/O Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAIO#NASDAQ">DAIO</a>) price target from $5 to $4. WestPark Capital analyst Kevin Garrigan maintained a Buy rating. Data I/O shares fell 4.3% to close at $2.67 on Friday. <a href="https://www.benzinga.com/quote/DAIO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc boosted The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) price target from $100 to $105. Keybanc analyst Justin Patterson maintained an Overweight rating. Trade Desk shares rose 1.7% to close at $92.43 on Friday. <a href="https://www.benzinga.com/quote/TTD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird raised argenx SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) price target from $490 to $515. Baird analyst Joel Beatty maintained an Outperform rating. argenx shares gained 1.7% to close at $494.46 on Friday. <a href="https://www.benzinga.com/quote/ARGX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt boosted Monolithic Power Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>) price target from $800 to $880. Rosenblatt analyst Hans Mosesmann maintained a Buy rating. Monolithic Power shares rose 4% to close at $821.78 on Friday. <a href="https://www.benzinga.com/quote/MPWR/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/40007546/anixa-biosciences-and-3-other-stocks-under-5-insiders-are-buying">Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying</a></li>
</ul>

ARGX

CHTR

DAIO

LGVN

MPWR

SCHW

TXRH

Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday

Needham analyst James Ricchiuti maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and raises the price target from $48 to $57.

Needham Maintains Buy on Cognex, Raises Price Target to $57

In the latest quarter, 9 analysts provided ratings for Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>), showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $49.78, a high estimate of $58.00, and a low estimate of $41.00. Surpassing the previous average price target of $44.43, the current average has increased by 12.04%.
<img src="https://www.benzinga.com/files/images/story/2024/1721750524_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Cognex. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kevin McCarthy</td>
<td>Vertical Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$58.00</td>
<td>-</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$55.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Helen Fang</td>
<td>HSBC</td>
<td>Announces</td>
<td>Buy</td>
<td>$52.00</td>
<td>-</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Joe Ritchie</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$41.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Tommy Moll</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Jay Huang</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Outperform</td>
<td>$55.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$48.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$44.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cognex. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cognex compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Cognex's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Cognex's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CGNX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Cognex analyst ratings.</a>
<h2>Get to Know Cognex Better</h2>
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's own cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.
<h3>A Deep Dive into Cognex's Financials</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Cognex's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2024, the company achieved a revenue growth rate of approximately 4.81%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Cognex's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.7% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.8%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Cognex's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.6% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.05.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Cognex Stands With Analysts

Reports Q3 revenue $235M, consensus $233.03M. "Cognex (CGNX) generated third quarter revenue and adjusted EBITDA margin in line with our guidance,"...

Cognex reports Q3 adjusted EPS 20c, consensus 19c

"Cognex (CGNX) expects revenue to be between $210 million and $230 million. This range represents a sequential decrease in revenue from Q3-24 to Q4...

Cognex sees Q4 revenue $210M-$230M, consensus $221.89M

Cognex Non-GAAP EPS of $0.20 beats by $0.01, revenue of $235M beats by $3.25M

Cognex raises quarterly dividend by 6.7% to  $0.08/share

Cognex Corporation (CGNX) Q3 2024 Earnings Call Transcript

Cognex Corporation 2024 Q3 - Results - Earnings Call Presentation

Cognex ( ($CGNX) ) has released its Q3 earnings. Here is a breakdown of the information Cognex presented to its investors. Cognex Corporation is a ...

Cognex Reports Solid Q3 2024 Financial Performance

KeyBanc analyst Kenneth Newman maintained a Hold rating on Cognex (CGNX – Research Report) today. The company's shares closed yesterday at $40.23. ...

Cognex (CGNX) Receives a Hold from KeyBanc

Dividend Champion, Contender, And Challenger Highlights: Week Of November 3

D.A. Davidson analyst Matt Summerville maintained a Hold rating on Cognex (CGNX – Research Report) today and set a price target of $39.00. The comp...

Cognex (CGNX) Receives a Hold from D.A. Davidson

ABBV

AMCR

APOG

CBAN

CHCT

CIVB

CRAI

CSWI

CWEN

EBTC

EFSI

FBIZ

FBMS

FCBC

FELE

FSBW

GABC

HBCP

HESM

HFWA

IBCP

JBHT

LKFN

MAIN

MATX

MPLX

NIDB

NXRT

ORRF

PAYX

SBFG

SIRI

SRCE

STBA

TXNM

UMBF

WDFN

WTFC

ZION

Press Releases

Cognex Names Dennis Fehr as Chief Financial Officer

Cognex Announces Second Quarter 2024 Earnings Release and Conference Call Dates

Dividends

Cognex Declares Quarterly Cash Dividend

Cognex Reports Second Quarter 2024 Results

Cognex Launches AI-Powered Counting Tool for In-Sight SnAPP Vision Sensors

General

Vision Sensor Market Size Worth $8.33 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners

Cognex Announces Third Quarter 2024 Earnings Release and Conference Call Dates

Cognex Reports Third Quarter 2024 Results

FLNC

Comments

Cognex

Cognex (CGNX) Opzioni

Cognex (NASDAQ:CGNX) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO